截至9月30日，正丹股份股东户数4.80万，较上期减少10.71%；人均流通股11103股，较上期增加 11.99%。2025年1月-9月，正丹股份实现营业收入18.95亿元，同比减少27.02%；归母净利润6.75亿元， 同比减少18.18%。 分红方面，正丹股份A股上市后累计派现7.13亿元。近三年，累计派现5.61亿元。 机构持仓方面，截止2025年9月30日，正丹股份十大流通股东中，南方中证1000ETF（512100）位居第 五大流通股东，持股243.56万股，相比上期减少2.94万股。香港中央结算有限公司位居第七大流通股 东，持股200.21万股，相比上期减少8.86万股。华夏中证1000ETF（159845）位居第八大流通股东，持 股144.74万股，相比上期减少3000.00股。 1月6日，正丹股份涨2.05%，成交额1.94亿元。两融数据显示，当日正丹股份获融资买入额2364.60万 元，融资偿还1395.65万元，融资净买入968.94万元。截至1月6日，正丹股份融资融券余额合计2.75亿 元。 融资方面，正丹股份当日融资买入2364.60万元。当前融资余额2.73亿元，占流通市值的2.7 ...

正丹股份今年以来股价涨2.32%，近5个交易日涨1.29%，近20日跌0.88%，近60日跌18.35%。 正丹股份所属申万行业为：基础化工-化学制品-其他化学制品。所属概念板块包括：小盘、低市盈率、 锂电池、融资融券、新材料等。 资料显示，江苏正丹化学工业股份有限公司位于江苏省镇江市润州区南山路61号国控大厦A座15楼，成 立日期2007年1月23日，上市日期2017年4月18日，公司主营业务涉及高端环保新材料的研发、生产和销 售。主营业务收入构成为：酸酐及酯类89.59%，高沸点芳烃溶剂10.40%，其他(补充)0.01%。 1月5日，正丹股份盘中上涨2.32%，截至10:48，报18.06元/股，成交6974.13万元，换手率0.73%，总市 值96.20亿元。 截至9月30日，正丹股份股东户数4.80万，较上期减少10.71%；人均流通股11103股，较上期增加 11.99%。2025年1月-9月，正丹股份实现营业收入18.95亿元，同比减少27.02%；归母净利润6.75亿元， 同比减少18.18%。 资金流向方面，主力资金净流入310.13万元，特大单买入0.00元，占比0.00%，卖出299.7 ...

Core Insights - The company has significantly improved its profitability, with total revenue reaching 1.429 billion yuan, a year-on-year increase of 3.37%, and net profit attributable to shareholders soaring by 120.35% to 630 million yuan [1] - The company has demonstrated excellent cost control, with total selling, administrative, and financial expenses amounting to -21.8736 million yuan, a reduction of 347.14% year-on-year [2] - The company's cash flow situation has improved markedly, with operating cash flow per share at 1.63 yuan, a year-on-year increase of 1221.64% [3] - The company's debt structure has been optimized, with interest-bearing liabilities decreasing from 160 million yuan in 2024 to 4.2051 million yuan in 2025, a reduction of 97.37% [4] - The main business analysis shows that anhydride and ester products contributed 88.38% of revenue, reaching 1.263 billion yuan, with a gross margin of 58.38% [5] - In the domestic market, the company achieved sales revenue of 850 million yuan, accounting for 59.47% of total revenue, while in the international market, sales revenue was 579 million yuan, making up 40.53% of total revenue [6] - The company is well-positioned for future growth in the specialty fine chemical sector, leveraging its technological, managerial, and brand advantages [7]

Core Insights - Zhengdan Co., Ltd. reported exceptional financial results for 2024, with a revenue of 3.48 billion yuan, a year-on-year increase of 126.31%, and a net profit attributable to shareholders of 1.19 billion yuan, reflecting a staggering growth of approximately 11,949.30% [2][3][5] Financial Performance - The company achieved a net profit of 1.19 billion yuan and a net profit excluding non-recurring items of 1.18 billion yuan, with year-on-year growth rates of about 11,949.30% and 25,313.81% respectively [3][4] - Quarterly revenue for 2024 was reported as follows: Q1: 518 million yuan, Q2: 864 million yuan, Q3: 1.21 billion yuan, Q4: 884 million yuan, with year-on-year growth rates of 28.80%, 155.08%, 214.25%, and 115.40% respectively [3][4] - The operating cash flow net amount reached 892 million yuan, marking a year-on-year increase of 431.03% [7] Market Dynamics - The significant growth in performance is attributed to the permanent closure of TMA production lines by U.S. manufacturers, leading to a notable increase in overseas demand for Chinese TMA [5][6] - The sales volume and price of TMA, the company's main product, saw substantial increases compared to the previous year, contributing to the overall revenue growth [5][6] Operational Efficiency - The company has successfully enhanced its production capacity and efficiency, with a significant increase in the utilization rates of TMA and TOTM products, leading to reduced marginal costs and improved profitability [5][6] - The comprehensive gross margin and net margin for 2024 were reported at 41.49% and 34.19%, respectively, reflecting increases of 37.64 percentage points and 33.55 percentage points year-on-year [6] Strategic Initiatives - Zhengdan Co., Ltd. is expanding its production capabilities, with plans to invest 350 million yuan in a green upgrade project for TMA production, aimed at addressing current capacity shortages and filling market gaps [6] - The company has also initiated a project for high molecular specialty resin monomers, further diversifying its product offerings [6] Financial Health - As of the end of 2024, the company's asset-liability ratio was 8.98%, a significant decrease of 21.58 percentage points from the previous year, indicating strong financial stability [7] - The company proposed a cash dividend of 368 million yuan, with a dividend payout ratio of 30.92%, reflecting a cautious approach to profit distribution despite strong earnings [7]